The Virus-killing chewing gum technology developed by researchers in the United States could soon make its way to Pakistan, offering a potential new tool in the fight against respiratory viruses such as COVID-19, influenza, and herpes.
Scientists at the University of Pennsylvania have created an experimental chewing gum infused with plant-based antiviral proteins. The aim is simple: trap and neutralize viruses in the mouth before they can spread further in the body or infect others.
According to early laboratory studies, the gum uses modified ACE2 proteins and a bean-derived compound known as FRIL. These ingredients are designed to bind with virus particles in saliva and reduce their ability to infect human cells. In controlled tests, researchers reported a significant drop in viral levels by more than 95% for certain viruses in lab samples.
Health experts say the concept is especially promising for high-risk environments. These include hospitals, schools, airports, and crowded public transport systems where viruses can spread quickly through close contact. A simple chewing gum could potentially add an extra layer of protection alongside existing preventive measures.
However, researchers also stress that the product is still in the experimental stage. Human clinical trials are required before any approval for public use. Scientists say the gum is not a substitute for vaccines or treatment but may support future prevention efforts.
If trials succeed, Pakistan could be among the first countries to introduce this product to help reduce virus spread in daily life.
For now, the development is still under study, showing ongoing efforts to find simple ways to fight infectious diseases.
